A Multicenter, Randomized, Double-blind, Placebo-controlled, Phase II Clinical Trial to Evaluate the Efficacy and Safety of Therapeutic Hepatitis B Vaccine (Mimogen-based) in Treating Chronic Hepatitis B Patients
Phase of Trial: Phase II
Latest Information Update: 05 Apr 2017
At a glance
- Drugs Hepatitis B vaccine (Primary)
- Indications Hepatitis B
- Focus Pharmacodynamics
- Sponsors Chongqing Jiachen Biotechnology
- 20 Nov 2016 Status changed from active, no longer recruiting to completed.
- 15 Jun 2012 Planned end date changed from 1 Oct 2011 to 1 Jun 2013 as reported by ClinicalTrials.gov.
- 15 Jun 2012 Status changed from completed to active, no longer recruiting as reported by ClinicalTrials.gov.